Related Experiment Video
Updated: Aug 29, 2025

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
Published on: February 22, 2019
The Human "Contaminome" and Understanding Infectious Disease
Patricia J Simner1, Steven L Salzberg1
1From the Department of Pathology, Division of Medical Microbiology (P.J.S.), the Department of Medicine, Division of Infectious Diseases (P.J.S.), and the Department of Biomedical Engineering (S.L.S.), Johns Hopkins School of Medicine, the Department of Computer Science and Center for Computational Biology, Whiting School of Engineering (S.L.S.), and the Department of Biostatistics, Bloomberg School of Public Health (S.L.S.), Johns Hopkins University, Baltimore.
No abstract available in PubMed .
More Related Videos
05:37Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
Published on: October 20, 2020
09:49Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
Published on: November 18, 2022
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Principles of Disease Surveillance
Viral Recombination
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.